GP
ASMB icon

GLG Partners’s Assembly Biosciences ASMB Stock Holding History

GLG Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-736
Closed -$225K – 332
2017
Q1 		$225K Buy
+736
New +$181K 0.01% 381

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

GLG Partners's ASMB Position: Q2 2017 in Review

GLG Partners sold out of Assembly Biosciences (ASMB) in Q2 2017, closing a stake of 736 shares — an estimated $225K sold.

GLG Partners first reported a position in ASMB in Q1 2017 and held it in 1 quarter. The position peaked at $225K in Q1 2017. 65 funds tracked by Wall St. Rank hold ASMB as of Q2 2017.

  • GLG Partners reported no remaining Assembly Biosciences position as of Q2 2017 after selling out during the quarter.
  • GLG Partners sold 736 Assembly Biosciences shares in Q2 2017, an estimated $225K.
  • GLG Partners first reported a position in Assembly Biosciences in Q1 2017 and held it in 1 quarter.
  • GLG Partners's Assembly Biosciences position peaked at $225K in Q1 2017.
  • 65 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2017.

Based on GLG Partners's 13F filing for Q2 2017, filed 14 Aug 2017.